| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |